ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
34 hedge funds and large institutions have $4.09M invested in Acorda Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
62% less call options, than puts
Call options by funds: $25K | Put options by funds: $66K
Holders
34
Holding in Top 10
–
Calls
$25K
Puts
$66K
Top Buyers
| 1 | +$102K | |
| 2 | +$97.2K | |
| 3 | +$26.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.8K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$13.8K |
Top Sellers
| 1 | -$357K | |
| 2 | -$22.1K | |
| 3 | -$19.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.76K |
| 5 |
VF
Virtu Financial
New York
|
-$6K |